Newron Pharmaceuticals S.p.A. Azioni nom. EO -,20

Sector and Industry

Healthcare, Biopharmaceuticals

Performance (1Y)

-

Market Cap

269.44 Mil.

P/E Ratio

0.00

Dividend Yield

0.00 %

Earnings per Share

-0.66 €

Peer Group

Company NameMarket CapRevenue Last Reported YearP/E RatioProfit Growth 1YLast PricePrevious Trading Day Change
Eli Lilly and Company864.54 Bil.57.78 Bil.46.82
+86.88 %
0.00
-
Johnson & Johnson425.70 Bil.83.48 Bil.18.82
+82.71 %
0.00
-
AbbVie Inc.343.94 Bil.54.21 Bil.96.78
-5.29 %
0.00
-
Roche Holding AG286.62 Bil.65.80 Bil.20.72
+58.45 %
0.00
-
AstraZeneca PLC244.91 Bil.52.09 Bil.27.55
+39.41 %
0.00
-
NOVARTIS AG 224.76 Bil.48.44 Bil.18.30
+12.45 %
0.00
-
Merck & Co. Inc.221.79 Bil.57.55 Bil.14.46
+2.25 %
0.00
-
Novo-Nordisk AS B193.52 Bil.41.49 Bil.14.11
+1.54 %
0.00
-
Amgen Inc.150.16 Bil.32.57 Bil.23.01
+80.77 %
0.00
-
Gilead Sciences Inc.129.70 Bil.26.10 Bil.18.10
+1,599.93 %
0.00
-

Facts & figures

Price data

TRADE PLATFORMBörse Stuttgart (XSTU)
LAST PRICE12.95 G0 Units
PRICE DETERMINATION TIME07/22/2026 / 07:53:38 AM
DAILY VOLUME (UNITS)0
DAILY HIGH / LOW12.9512.95
PREV. DAY'S PRICE12.95 (07/21)
CHANGE DAY BEFORE
+0.00
0.00 %
52 WEEK HIGH / LOW (-) (-)
More Price Information

Key Figures (in EUR)

2023202420252026e2027e
EARNINGS PER SHARE
-0.910.85-0.66-1.11-0.92
DIVIDENDS PER SHARE
0.000.000.000.000.00
DIVIDEND YIELD IN %
0.00 %0.00 %0.00 %--
DIVIDEND GROWTH IN %
-----
PRICE - EARNINGS RATIO
-10.98---
PRICE - BOOK RATIO
-130.18---
PRICE - SALES RATIO
10.043.7526.57--
PRICE - CASH FLOW RATIO
--15.71--
Further Key Figures

Master Data

WKN
A0LF18
ISIN
IT0004147952
SYMBOL
NP5
EXCHANGE SEGMENT
Freiverkehr
TYPE OF FINANCIAL INSTRUMENT
Equity
DENOMINATION
NEWRON PHARMACEUT. EO-,20
INDEX MEMBERSHIP
-
TRADING SEGMENT
-
TRADING HOURS
07:30:00 AM - 10:00:00 PM
TRADING CURRENCY
Euro
NOMINAL CURRENCY
Swiss Franc
SETTLEMENT CURRENCY
Euro
SECTOR AND INDUSTRYHealthcare, Biopharmaceuticals
NUMBER OF SHARES
20.81 Mil.
MARKET CAPITALISATION
269.44 Mil.

Performance overview

1W1M3M6M1Y3Y5YYTD
PERFORMANCE
3.60 %
-1.89 %
------
HIGH12.9514.20------
LOW12.1012.10------

Dividende

pro Aktie
NEWRON PHARMACEUT. EO-,20 does not deliver dividend information

Company profile

Newron Pharmaceuticals SpA operates as a biopharmaceutical company. It focuses on the development of novel therapies for patients with diseases of the central and peripheral nervous system. The firm's products include Xadago (safinamide), Evenamide (NW-3509) and Ralfinamide. The company was founded by Luca Benatti, Ruggero Fariello and Patricia Salvati in 1999 and is headquartered in Bresso, Italy.

Shareholder Structure (Top 10)

AnteilName
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available

Analyst Rating

Ø-Target Price DistanceNot Available
Current Price
Not Available
Ø-Target Price
Not Available
Average ResultNot Available
Buy0
Overweight0
Hold0
Underweight 0
Sell0

Company Events

No company events available.